Abstract
Allium sativum (garlic) has been used since prehistoric times in various cultures as a spice as well as a medicine to combat microbial and fungal infections, help in cardiovascular problems, stimulate immunological system or stop tumor growth. Epidemiological studies indicate that increased consumption of garlic is inversely correlated with the risk of different types of cancer in various human populations. Garlic preparations inhibit chemically induced cancers in animals. This chemo-preventive activity is attributed to organosulfur compounds which modulate Phase I and II detoxification enzymes, thus inhibit pro-carcinogen activation and/or enhance carcinogen neutralization and removal. Laboratory studies also indicate that garlic compounds suppress cancer development at post-initiation phases inducing cell cycle block and apoptosis as well as inhibiting angiogenesis and metastasis. Results of the in vitro studies explain the mechanisms of action of garlic organosulfurs at the molecular level, which is a necessary step before their clinical use for cancer patients. This chapter reviews the evidence on garlic chemo-preventive activities in human populations, animal models and limited clinical trials. It also summarizes the current knowledge on molecular mechanisms of its anti-proliferative activity toward cancer cells, possible interactions with drugs and impact on immune system—factors that should be considered before use of garlic compounds in cancer therapy.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
10.1 Introduction
Allium sativum (garlic) is a member of the Liliaceae family, which also includes onions, leeks, scallions or chives. Garlic is rich in sulfur-containing compounds, which contribute to its characteristic odor, taste and beneficial health effects. Thus, it has been used as a spice as well as a medicine since prehistoric times in various cultures (Rivlin 2001). Ancient Egyptians, Jews, Greeks and Romans consumed garlic to increase their strength, courage in battle and enhance work capacity. The Codex Ebers, an Egiptian medical text dating to 1500 BC, mentions garlic as a remedy for skin diseases, poisoning, heart problems, and abnormal growths (tumors). Hippocrates prescribed garlic for protecting the skin against toxins or treating abdominal tumors. In ancient China and Japan garlic was thought to provide energy, lift depression, and improve male potency, aid respiration and digestion. In India, 2,000 years ago, garlic was used to treat arthritis and heart disease.
In the modern era health benefits of garlic are well recognized and include anti-microbial, anti-fungal, lipid and glucose lowering, anti-thrombotic and immunostimulatory properties, as well as anticancer activity. The evidence for the chemo-preventive and therapeutic application of garlic preparations is reviewed below.
10.2 Bioactive Compounds Derived from Garlic
Garlic bulbs contain approximately 65% water, 28% carbohydrates, 2.3% organosulfur compounds, 2% protein, 1.2% free amino acids and 1.5% fiber (Block 1985). The biological activity of garlic is attributed to organosulfur compounds (OSCs). The primary sulfur-containing compounds in whole and intact garlic are γ-glutamyl-S-alk(en)yl-L-cysteins. They are precursors of odorless alliin (S-alk(en)yl-L-cysteine sulfoxide). Processing of garlic bulbs (cutting, chewing or crushing) releases a vacuolar enzyme, alliinase, which acting upon alliin gives rise to allicin (diallyl thiosulphate), the principal active substance of fresh garlic extract, discovered by Cavallito in 1944 (Cavallito and Bailey 1944). Allicin is unstable and breaks down readily to produce odorous oil-soluble sulfur compounds, including diallyl sulfide (DAS), diallyl disulfide (DADS), diallyl trisulfide (DATS), allyl methyl trisulfide, dithiins and ajoenes (Fig. 10.1). Water-soluble garlic sulfur compounds, such as S-allylcysteine (SAC) or S-allylmercaptocysteine (SAMC), are products the bioconversion of γ-glutamyl-S-alk(en)yl-L-cysteins which takes place during natural aging of plants (Fig. 10.1).
The composition and thus biological activity of garlic extracts depends on the mode of preparation. For example, rehydratated standardized powder of crushed garlic is almost devoid of alliin because rehydratation activates alliinase. It contains allicin (13.5 mg/g DW), allyl sulfides (0.15 mg/g DW, including DATS- 56–87% and DADS- 9–31%), γ-glutamyl-S-allylcysteine (5.9 mg/g DW), γ-glutamyl-S-trans-1-propenylcysteine (5.8 mg/g DW), S-allylcysteine (0.28 mg/g DW), S-allylmercaptocysteine (< 0.02 mg/g DW) (Lawson and Wang 2005). Garlic oil obtained by steam distillation contains diallyl- (57%, including DADS and DATS), methyl allyl- (37%) and dimethyl oligosulphides (6%) (Lawson et al. 1991). On the other hand, oil macerated garlic, produced by homogenizing chopped garlic in vegetable oil, contains primarily vinyldithiins (70%), dialk(en)yl sulfides (18%) and ajoenes (12%) (Lawson et al. 1991). Aged garlic extract (AGE) which results from prolonged extraction of fresh garlic in ethanol solution at room temperature is devoid of allicin and contains water-soluble organosulfurs, such as S-allylcysteine, S-allylmercaptocysteine and lipid-soluble DAS, DADS, diallyl polysulfides and others (Weinberg et al. 1993) (Fig. 10.1).
10.3 Human Studies
Epidemiological and intervention studies were carried out to determine the association between garlic consumption and cancer risk (Table 10.1). The majority of these studies were related to addressing the chemo-preventive role of garlic consumption in regard to stomach and colon cancer. In the case of stomach cancer, most of the studies were population studies carried out in China and regarded mainly the comparison of death rates or cancer incidents in low-risk and high-risk areas for stomach cancer. The lower death rates/cancer incidences were attributed to the consumption of garlic. In the low-risk Cangshan County the consumption of garlic was reported to be 9 times higher than in the high-risk Linqu County of the Shandong Province (You et al. 1998, 1999). A 3-fold increase in garlic intake was associated with the low cancer incidence in a low-risk area in the Jiangsu Province (Takezaki et al. 1999). In another study the increased consumption of Allium vegetables, including garlic, was found to be inversely associated with the risk of stomach cancer (Gao et al. 1999). Although these results are promising they do not provide the necessary information regarding the validation of the food-frequency assessment, therefore according to the FDA evidence-based review system, are not statistically significant (Kim and Kwon 2009).
In a case-control study carried out in China a group of 564 patients with stomach cancer was compared to a control group of 1,131 residents from a high-risk area. The study showed that the consumption of various Allium vegetables, including garlic, reduced the occurrence of stomach cancer (You et al. 1989). Another case-control study performed in Korea indicated a significant decrease in the risk of gastric cancer with the increased intake of garlic (Kim et al. 2002).
In a double-blind intervention study the effects of high doses of allitridum (DATS) and low doses of selenium were examined on the occurrence of gastric cancer in the Qixia County, Shandong Province. Case subjects were selected based on criteria such as medical history of stomach disorder, family history of stomach cancer, alcohol consumption and/or smoking. 2,526 case subjects were enrolled in the trail and were given allitridum (200 mg/day) and selenium (100 μg every other day) for 1 month each year for 3 consecutive years. The control group consisted of 2,507 subjects, which were given a placebo. Five years after the termination of the study the occurrence of cancers was registered. 35 and 51 cases of malignant tumors were documented in the intervention group and control group, respectively, and the morbidity rates of all cancers in the intervention group declined by 22%. In the case of gastric cancer 10 and 19 cases were recorded in the intervention and control groups, respectively, and the morbidity rate declined by 47.3% in the intervention group (Li et al. 2004).
In a latter study carried out in the Linqu County of the Shandong Province, a long-term trial was conducted to evaluate, among others, the effects of AGE and steam distilled garlic oil on the development of advanced precancerous gastric lesions. The study was a factorial-design trial, in which 3,365 case subjects were given a one-time antibiotic treatment for Helicobacter pylori infection and/or 7.3 years of oral vitamin (vitamin C, E and selenium) supplementation and/or garlic supplementation. The results showed no association between long-term garlic supplementation and precancerous gastric lesions (You et al. 2006). The results of a cohort study carried out in the Netherlands and a case-control study carried out in Sweden showed that intake of garlic supplements did not correlate with the risk of stomach cancer (Dorant et al. 1996b; Hansson et al. 1993).
In the United States two large cohort studies were conducted to determine the correlation between garlic intake and colorectal cancer. In the first study, The Iowa Women’s Health Study, a group of 41,837 women were interviewed for their dietary habits and were then monitored for cancer incidence over a period of five years. During this time 212 cases of colon cancer were documented. The results of the study showed that the consumption of more than 1 serving of garlic per week significantly decreased the risk of colorectal cancer (Steinmetz et al. 1994). In another cohort study, 47,949 men were followed for approximately 6 years. 205 cases of colon cancer were identified during this period. The results, however, did not associate garlic intake with colon cancer (Giovannucci et al. 1994). These results were further confirmed by a case-cohort study carried out in the Netherlands. Dietary habits of 120,852 cases were evaluated with a food-item frequency questionnaire. After a 3.3-year follow-up, 443 case subjects diagnosed with colorectal cancer and 3,123 randomly selected healthy control cases were analyzed and no association between garlic intake and colon cancer risk was reported (Dorant et al. 1996a).
In a case-control study conducted in Switzerland, including 223 case patients and 491 control subjects, the correlation between garlic consumption and colorectal cancer was shown (Levi et al. 1999). These results were supported by another case-control study carried out in Italy and Switzerland. 1,394 colon cancer cases, 886 rectal cancer cases and 4,765 control subjects were examined. The specific amounts of garlic intake were not given since garlic intake was specified in terms of qualitative variables such as non-use, low, intermediate or high. It was showed that intermediate to high use of garlic is associated with the reduced risk of colorectal cancer (Galeone et al. 2006). Two other case-control studies carried out in the United States and Hawaii confirmed that garlic intake was inversely associated with the development of adenocarcinomas (Le Marchand et al. 1997; Witte et al. 1996). The results of these two studies, however, where not considered as significant, as assessed by the FDA evidence-based review system.
A double-blind, intervention trial carried out in Japan was performed to evaluate the effects of AGE on patients with colorectal adenomas. 51 patients diagnosed with colorectal cancer were divided into an intervention group (high dose AGE, 2.4 ml/day) and control group (low dose, 0.16 ml/day). The results, verified after 6 and 12 months, showed no effect of AGE on the incidence of polyps, however AGE was found to decrease the size of existing carcinomas. Due to the low number of subjects and short duration of the trial, the results can only suggest the preventative role of AGE on colorectal adenocarcinomas (Tanaka et al. 2004).
The association between garlic consumption and the reduced risk of prostate cancer was also examined. In a case-control study carried out in England, 328 men diagnosed with prostate cancer and the same number of population controls were examined regarding their dietary habits, which included the consumption of garlic. The results showed that the intake of two or more servings of garlic per week was not associated with the reduction of prostate cancer risk (Key et al. 1997). In another study carried out in Shanghai, the association between garlic consumption and reduced prostate cancer risk was much more pronounced. 238 men diagnosed with prostate cancer and 471 men, as population control subjects, were interviewed to determine the amounts of Allium vegetables they consumed. The results showed that men who consumed more than 10.0 g/day had a significantly lower risk of prostate cancer compared to those who consumed less than 2.2 g/day (Hsing et al. 2002). Two other studies did not report an association between garlic intake and prostate cancer risk (Galeone et al. 2006; Kirsh et al. 2007).
Garlic consumption was also found to be inversely related to the risk of breast cancer as shown in a European case-control study conducted in France. 345 women diagnosed with primary breast carcinoma and 345 healthy women were evaluated for their dietary habits. The results of the study showed that an increase in garlic intake (more than 7 servings per week) reduced the risk of breast cancer (Challier et al. 1998). A case-control study carried out in Italy and Switzerland did not report an association between garlic intake and risk of breast cancer (Galeone et al. 2006). Similarly, a cohort study carried out in the Netherlands also reported no correlation. A cohort of 469 patients with breast cancer and 1,713 control subjects were analyzed after a 3.3-year follow-up and no association of garlic intake with breast cancer risk was reported (Dorant et al. 1995). The associations between garlic consumption and other cancers are presented in Table 10.1.
On the basis of the presented studies it is clear that to some extent there is a correlation between garlic intake and some types of cancer. The published epidemiological studies suggest the protective role of garlic against colon and stomach cancer. However, these studies do have some limitations, which decrease their credibility. One of these limitations is the diverse efficacy of the different types of garlic preparations consumed by the case subjects. These studies do not provide any consistency as to the type of preparation used, therefore too many variables are introduced. Moreover, the chemical composition of the garlic preparation can be affected through the method of preparation, such as cooking, extracting, etc. Another limitation is providing the appropriate data as to the amounts of garlic consumed. These are often not precisely specified and are reported as frequency instead of amount. Therefore, in order for the results of the studies to be more consistent, clinical trials need to be carried out to provide more credible evidence as to the association between garlic consumption and cancer development.
10.4 Evidence of the Anticancer Activity of Garlic in Animal Models
The anti-carcinogenic properties of garlic have been examined in animal experimental models. Garlic in the form of various preparations, administered either intragastrically or percutaneously, has been shown to inhibit the carcinogenesis of the colon, skin, tongue, breast and liver, induced by a variety of carcinogens (Table 10.2). For example, the chemo-preventive effects of garlic on 1,2-dimethylhydrazine (DMH)-induced colon cancer were studied in rats. Garlic was fed to rats and DMH was injected subcutaneously for 20 weeks, once a week. The results of the experiments showed that garlic significantly reduced the incidence of tumor formation in the group of rats, in which garlic constituted 2.5% of their diet (Cheng et al. 1995).
Likewise, garlic-derived compounds have been studied for their chemo-preventive activities. DAS inhibited tumor formation of the esophagus, lung, skin, forestomach, colon and breast, whereas contradictory results were obtained in the case of liver carcinogenesis (Table 10.2). DADS was reported to provide protection against chemically induced carcinogenesis of the skin, colon, kidney, fore-stomach, prostate and breast. DATS inhibited forestomach-induced carcinogenesis, whereas SAC, colon-induced carcinogenesis. Contradictory results were obtained with SAC regarding N-methylnitrosourea (MNU)-induced breast cancer, the inconsistencies of the obtained results could be due to the differences in the administered doses of SAC (Table 10.2).
The anti-carcinogenic properties of OSCs were found to be associated with the number of sulfur atoms in their chemical structure. In a study evaluating the protective effects of OSCs on benzo[a]pyrene (BP)-induced neoplasia of the forestomach and lungs, allyl methyl trisulfide (AMT), allyl methyl disulfide (AMD), DAS and DATS inhibited forestomach carcinogenesis, whereas only DAS and AMD inhibited lung carcinogenesis. These results suggested that the number of sulfur atoms in the molecule could determine the organ sites at which protection against carcinogens takes place (Sparnins et al. 1988). The number of allyl groups has also been shown to influence the inhibitory capacities of OSCs. Studies showed that OSCs containing allyl groups are more potent inhibitors of carcinogenesis (Sparnins et al. 1986, 1988).
Apart from the chemo-preventive properties of garlic-derived OSCs, the anticancer activities of these compounds have also been determined in animal xenograft tumor models (Table 10.3). DADS was found to inhibit the growth of HCT-15 human colon tumor xenografts in nude mice. DADS was either intraperitoneally or intragastrically administered to mice, however, its efficacy was 2 times higher when injected intraperitoneally, reducing tumor volume by 69%. The efficacy of DADS was similar to that of 5-fluorouracil (5-FU), a recognized chemo-therapeutic agent used in advanced colon cancer therapy. The concurrent treatment of DADS with 5-FU reduced the toxicity of 5-FU, improving white blood cell counts and the decrease in spleen weight and elevated plasma urea (Sundaram and Milner 1996c). DADS also suppressed the growth of KPL-1 breast cancer xenografts in nude mice. DADS (1 or 2 mg) was injected intraperitoneally 3 times per week from the day of tumor injection. After 35 weeks a 45% reduction in primary tumor weight was observed in DADS-treated mice, which was associated with reduced cell proliferation (Nakagawa et al. 2001). DADS also suppressed the growth of H-ras oncogene transformed tumor xenografts in nude mice. DADS was administered orally 3 times a week from the day of tumor injection and the results showed that the growth of tumors was significantly delayed in comparison with control mice (Singh et al. 1996).
DATS inhibited the growth of PC-3 human prostate cancer xenografts in athymic mice. DATS was administered orally (6 μmoL, thrice weekly) to nude mice with implanted PC-3 cells and after 20 days of therapy the average tumor volume in DATS-treated mice was three-fold smaller than in control mice. Moreover, the treatment did not cause weight loss or any other side effects (Xiao et al. 2006a).
S-allylcysteine was reported to inhibit the growth of human prostate CWR22R cancer xenografts in mice with no detectable side-effects. The effects of SAC were associated with the inhibition of tumor proliferation and invasion, as shown by E-cadherin restoration, and increased apoptosis (Chu et al. 2007).
Thiacremonone, a novel sulfur compound isolated from garlic, was reported to inhibit the growth of SW620 human colon tumor xenografts in mice. Furthermore, the co-treatment of thiacremonone with low doses of docetaxel (1 mg/kg) increased the susceptibility of tumor cells to docetaxel, most probably through the inactivation of NF-κB. This combined treatment reduced docetaxel toxicity and greatly increased the life span of mice from 45 to 110 days. Therefore, these results indicate that thiacremonone could be used in association with other chemo-therapeutical drugs, enabling lower dose chemo-therapuetical treatment (Ban et al. 2007, 2009).
Another OSC, SAMC, was also reported to increase the efficacy of docetaxel, as shown in a prostate CWR22R cancer xenograft model. The combination was 53% more potent in inhibiting tumor growth than docetaxel alone (Howard et al. 2008).
The anti-metastatic activities of garlic compounds have also been studied in vivo. The effects of SAMC were examined on the growth and tumor spread of prostate cancer with the use of a fluorescent orthotopic severe combined immunodeficient (SCID) mouse model. PC-3 cells, constitutively expressing GFP, were injected into the dorsal prostate of SCID mice and after 30 days, metastatic GFP-expressing tumors in lungs and adrenals were identified. The oral administration of SAMC (300 mg/kg/d) not only inhibited the growth of primary tumors by 71% but also reduced the number of lung and adrenal metastases by 85.5% and reduced the number of circulating tumor cells by 91%. No toxic effects or organ pathology were observed in SAMC-treated mice (Howard et al. 2007). Moreover, studies have shown that 200 mg/kg SAMC protects against toxin-induced liver damage with an efficacy similar to that of N-acetylcysteine, a hepatoprotective agent (Sumioka et al. 1998). Another garlic constituent, ajoene, was also found to inhibit lung metastasis of B16/BL6 melanoma cells in mice (Taylor et al. 2006).
The effects of OSCs have also been examined in targeted therapy with the use of nanoparticles. In these studies polybutylcyanoacrylate nanoparticles, filled with DATS (DATS-PBCA-NP) were targeted against orthotopically transplanted liver hepatocellular HepG2 cells in mice. DATS-PBCA-NP was found to suppress the proliferation and induce apoptosis in transplanted cells leading to a significant inhibition of tumor growth (Zhang et al. 2007).
The results of the in vivo experiments are consistent and indicate the chemo-preventive, anti-proliferative and anti-metastatic properties of garlic and its constituents.
10.5 Molecular Targets of Garlic Compounds—In Vitro Studies
A large body of research on the chemo-preventive and anticancer activities of garlic constituents has been performed on cultured cells, the best model for the investigation on the molecular mechanism of their action and important step for identification of mechanism-based biomarkers which might be useful in future clinical trials and therapies. It appears that compounds from garlic, besides prevention of initiation and promotion of carcinogenesis, act at later phases inhibiting cancer cell proliferation and viability.
Growth suppressive activity of garlic compounds, documented for cancer cells of different origin, relies on their ability to block cell cycle progression and/or induce programmed cell death (Table 10.4). Interestingly, most garlic-derived OSCs induce accumulation of cancer cells with 4 N DNA content which indicates a block in G2, M or both phases of the cell cycle.
Progression of cells from G2 into mitosis depends on the Cdk1-cyclin B1 complex, whose activity is controlled at multiple levels, such as production and association of components, their intracellular localization and reversible phosphorylation. Dephosphorylation of Cdk1 at Thr14/Tyr15 by Cdc25 family of dual-specificity phosphatases is crucial for the activity of the complex and Cdc25s activities are under control of DNA damage checkpoint kinases Chk1 and Chk2 (Peng et al. 1997; Sanchez et al. 1997). Garlic compounds negatively influence activation of the Cdk1-cyclin B1 complex. It has been demonstrated that DADS decreased Cdk1 kinase activity within 4 h of treatment in HCT-15 colon cancer cells (Knowles and Milner 1998). It correlated with reduced complex formation between Cdk1 and cyclin B1 despite the time-dependent accumulation of cyclin B1 as well as increased inactivating phosphorylation of Cdk1 and drop in Cdc25C protein level upon DADS treatment (Knowles and Milner 1998, 2000). The same compound induced inactivating phosphorylation of Cdk1 in HL-60 human leukemia cells (Tan et al. 2004) or decreased Cdk1 kinase level in PC-3 human prostate cancer cells in a dose-dependent manner (Arunkumar et al. 2006b). Similarly, DATS induced accumulation of cyclin B1 and impaired Cdk1/cyclin B1 activity in J5 liver cancer cells (Wu et al. 2004), decreased Cdc25C and Cdk1 levels and induced Tyr15 phosphorylation of Cdk1 in H358 non-small and H460 large cell lung cancer cell lines (Xiao et al. 2009).
The mechanism of OSC-induced G2/M arrest has been well elucidated for DATS in a prostate cancer cell line model (Herman-Antosiewicz and Singh 2005; Antosiewicz et al. 2006; Herman-Antosiewicz et al. 2007, 2010; Xiao et al. 2005a, 2006b). The DATS-induced Tyr-15 phosphorylation of Cdk1 and inhibition of Cdk1/cyclin B1 activity in PC-3 cells was accompanied by down-regulation of total Cdc25C protein level an increased inhibitory phosphorylation of Cdc25C (Ser216), which was mediated by checkpoint kinase-1 (Chk1) (Herman-Antosiewicz and Singh 2005; Xiao et al. 2005a). Activating phosphorylations of Chk1 (Ser317) and other kinases engaged in DNA damage checkpoint such as Chk2 (Thr68) and ATM (Ser1981) as well as histone H2A.X, whose phosphorylation at Ser139 serves as an indicator of double strand break, points toward the genotoxic activity of DATS (Herman-Antosiewicz and Singh 2005). Whether DATS directly reacts with DNA or its effect is indirect through generation of reactive oxygen species needs to be elucidated. Antioxidants such as N-acetylcysteine (NAC) or EUK134 protected against the decrease in Cdc25C level and cell cycle arrest induced by DATS (Antosiewicz et al. 2006; Xiao et al. 2005a). Genotoxic activity of DADS was also reported by Aquilano et al. (2007) in SH-SY5Y human neuroblastoma cells and it was counteracted by over-expression of neuronal nitric oxide synthase.
It was also documented that DATS induced prometaphase arrest with characteristic changes in the tubulin network, chromatin condensation and increased Ser10 phosphorylation of histone H3 (Herman-Antosiewicz and Singh 2005) as well as accumulated anaphase promoting complex (APC) substrates (securin and cyclin B1) and hyperphosphorylated APC components (Herman-Antosiewicz et al. 2007). Interestingly, Chk1 and its upstream kinase, ATR, appeared to be mediators of DATS-induced mitotic arrest (Herman-Antosiewicz and Singh 2005; Herman-Antosiewicz et al. 2007).
Mitotic block or apoptosis induced by garlic OSCs might be the result of a disruption of the microtubule network in cancer cells by these compounds. For example, treatment of SW480 human colon cancer cells or NIH 3T3 mouse fibroblasts with 150 μmol/L SAMC caused rapid microtubule depolymerization and cytoskeleton disruption in interphase cells and perturbed spindle formation in mitotic cells. SAMC (300 and 1,000 μmol/L) induced microtubule depolymerization and inhibited de novo tubulin polymerization in vitro presumably because of direct interaction with sulfhydryl groups on tubulin (Xiao et al. 2003, 2005b). DADS (112 or 280 μmol/L) arrested SW480 in both G2 and M phase of the cell cycle. It was also shown that DADS at high concentrations (560 and 1,120 μmol/L) caused a 30% inhibition of de novo tubulin polymerization but did not induce depolymerization of polymerized tubulin in vitro (Xiao et al. 2005b). Interphase NIH 3T3 cells treated with 56 μmol/L DADS revealed disorganized microtubule cytoskeleton network. Interestingly, although mitotic spindles looked normal, “lagging” chromosomes were observed in DADS-treated cells, which were suggested to cause mitotic block and appearance of multinucleated cells (Xiao et al. 2005b). DATS, but not DADS, has been shown to induce mitotic arrest in HCT-15 and DLD-1 human colon cancer cells and it was associated with the disruption of the microtubule network in interphase cells and inhibition of spindle formation in mitotic cells (Hosono et al. 2005). This study revealed that DATS -treated β tubulins were oxidatively modified at residues Cys12 and Cys354 to form S-allylmercaptocysteine (Hosono et al. 2005). Another oil soluble garlic compound, Z-ajoene, caused G2/M cell cycle arrest and dose-dependent reduction in microtubule network of PtK2 normal marsupial kidney cells and inhibited tubulin polymerization in vitro (Li et al. 2002a).
OSCs may affect cancer cell proliferation through modification of the histone acetylation level, which has an impact on gene expression. It has been reported that DADS and more potently its metabolite, allyl mercaptan, increased acetylation of H4 and H3 histones in DS19 cells and K562 human leukemic, rat hepatoma and human breast cancer cells and it was suggested that histone acetylation mediates the differentiation process of erythroleukemia cells (Lea et al. 1999). Growth inhibitory effects of allicin, SAMC and SAC on DS19 cells and SAMC on Caco-2 human colon and T47D human breast cancer cells have been correlated with increased histone acetylation, although its mechanism remains to be characterized (Lea et al. 2002). DADS-induced accumulation of Caco-2 and HT-29 colon tumor cells in G2/M phase of the cell cycle was also associated with the inhibition of histone deacetylase, hyperacetylation of H3 and H4 histones and up-regulation of mRNA and protein levels of p21, an inhibitor of cyclin-dependent kinases engaged in the progression of G1 and G2 phases of the cell cycle (Druesne et al. 2004a, b). The question as of the crucial role of p21 in DADS-induced cell cycle arrest awaits further investigation. The increase in the p21 protein level has been observed in DATS-treated PC-3 cells, however, silencing of p21 expression through specific antisense RNA had no effect on DATS-induced G2/M cell cycle arrest (Xiao et al. 2005a).
Garlic-derived OSCs have been reported to induce programmed cell death of cancer cells and a majority of them activated the so called intrinsic (mitochondrial) apoptotic pathway, which is characterized by a loss of mitochondrial membrane potential, release of pro-apoptotic molecules, activation of caspase-9 and -3 and is regulated by the Bcl-2 family members. Numerous studies showed that treatment with garlic compounds decreases the ratio of anti-apoptotic (e.g. Bcl-2, Bcl-xL) to pro-apoptotic (e.g. Bax, Bak, Bid) Bcl-2 family members (Table 10.4). For example, in DAS or DADS-treated H460 and H1299 lung cancer cells as well as SH-SY5Y neuroblastoma cells the ratio of Bax/Bcl-2 was increased in comparison to control cells (Hong et al. 2000; Karmakar et al. 2007). A time-dependent up-regulation of Bax protein levels with concomitant down-regulation of Bcl-xL protein levels has been reported for DADS-treated MDA-MB-231 breast cancer cells (Nakagawa et al. 2001). Z-ajoene-induced apoptosis of HL-60 cells was associated with caspase-mediated cleavage of Bcl-2, which was inhibited by the antioxidant, NAC (Li et al. 2002b). Another study revealed an increase in production of peroxide in ajoene-treated HL-60 cells and NAC partially prevented ajoene-induced ROS generation as well as apoptosis (Dirsch et al. 1998). DATS-induced cell death of PC-3 and DU-145 prostate cancer cells, which was caused by a decrease in Bcl-2 level and its JNK-mediated hyperphosphorylation. This resulted in reduced Bcl-2:Bax interaction and activation of mitochondrial pathway of apoptosis (Xiao et al. 2004). Moreover, DATS-induced JNK activation and apoptosis were inhibited by over-expression of catalase which implies the involvement of hydrogen peroxide in apoptosis induction (Xiao et al. 2004). Other members of the Bcl-2 family have been shown to regulate OSC-induced apoptosis as well. DATS, reducing Akt activity in PC-3 and DU145 cells and consequently the phosphorylation of its substrate Bad, caused translocation of Bad to mitochondria which contributed to the activation of the intrinsic cell death pathway (Xiao and Singh 2006). DADS or garlic extract induced JNK-dependent phosphorylation of pro-apoptotic BimEL that resulted in its translocation to the mitochondria and apoptosis induction in MDA-MB-435 breast cancer cells (Lund et al. 2005).
Oxidative stress is a common phenomenon contributing to apoptosis induction by OSCs in cancer cells. For instance, DADS induced hydrogen peroxide formation and apoptosis in HL-60 leukemia (Kwon et al. 2002) and T-24 bladder cancer cells (Lu et al. 2004). DADS-induced ROS formation in SH-SY5Y neuroblastoma cells was evident as early as 15 minutes after its administration and it was followed by oxidation of cellular lipids and proteins (Filomeni et al. 2003). It was associated with JNK pathway activation. Over-expression of Cu, Zn superoxide dismutase or pretreatment with the spin trapping molecule 5,5’-dimethyl-1-pyrroline N-oxide protected against DADS-induced ROS generation, oxidative damage of cellular macromolecules and apoptosis. Moreover, cell permeable JNK inhibitor I protected against DADS-induced apoptosis but not G2/M cell cycle arrest (Filomeni et al. 2003). JNK1 pathway has also been activated and played a role in apoptosis induction by the water-soluble garlic compound, SAMC in SW480 and HT-29 colon cancer cells (Shirin et al. 2001; Xiao et al. 2003).
An increase in intracellular free calcium concentration is another response of cancer cells to garlic OSCs (Table 10.4). Park et al. reported biphasic DADS-induced elevation in Ca2+: rapid with peak value at 3 minutes and slow and sustained elevation till 3 hours after the addition of DADS (Park et al. 2002). It was followed by an increase in hydrogen peroxide level and caspase-3 activation. Interestingly, although NAC or catalase treatment prevented the accumulation of H2O2 and apoptosis, they had no effect on Ca2+ elevation. On the other hand, cellular calcium chelator abolished the DADS-induced elevation of intracellular calcium, H2O2 levels and caspase-3 activation which strongly suggested that changes in calcium homeostasis might be the earliest events in DADS-induced cytotoxicity (Park et al. 2002). It has been shown that both DAS and DADS cause an increase in Ca2+ in SH-SY5Y cells which led to activation of calpains, the non-caspase cysteine proteases, which contribute to cell death by the induction of the mitochondrial pathway of apoptosis (Karmakar et al. 2007). DAS, DADS, and DATS induced apoptosis of human glioblastoma T98G and U87MG cells which was accompanied by an increase in cytosolic free Ca2+, expression of calreticulin and activation of caspase-4 which indicates involvement of endoplasmic reticulum stress (Das et al. 2007).
Summarizing, garlic OSCs are able to increase ROS formation and/or modify cellular proteins (S-thiolation). They induce oxidative and genotoxic stress and abnormalities in cytoskeleton function in cancer cells which lead to G2 and M checkpoint activation, disruption of calcium homeostasis and induction of the mitochondrial pathway of apoptosis.
In vitro studies demonstrate anti-angiogenic and anti-metastasis properties of garlic preparations. For instance, AGE reduced invasive potential and motility of human and rat endothelial cells by 30% in matrigel chemo-invasion assays as well as capillary-like tube formation in 3-dimensional collagen matrix assays (Matsuura et al. 2006). DATS decreased capillary-like tube formation and migration of human umbilical vein endothelial cells and at the molecular level it was correlated with Akt inactivation and reduced level of VEGF receptor 2 and secretion of VEGF (Xiao et al. 2006b). Also DADS and DAS inhibited endothelial cell proliferation and migration reducing matrix metalloproteinases MMP-2 and MMP-9 (Thejass and Kuttan 2007a, b). Water soluble SAC inhibited MDA-MB-231 breast cancer cell motility and invasion, which was accompanied by increased expression of E-cadherin and reduced MMP-2 level and activity (Gapter et al. 2008).
10.6 Antioxidant and Pro-oxidant Activity of Garlic and OSCs
There are several reports demonstrating that garlic exerts direct or indirect antioxidant activity (Imai et al. 1994). Indirect activity is related to the ability of garlic to stimulate the activity of glutathione peroxidase (GPx), glutathione reductase and superoxide dismutase in different experimental models. Moreover, AGE, SAC and SAMC exhibited direct radical scavenging activity. In addition, it was found that AGE had the capacity to chelate copper ions and inhibit copper dependent lipid peroxidation (Dillon et al. 2003). Dietary supplementation with AGE for 14 days reduced plasma and urine concentrations of 8-iso-prostaglandin F (2 alpha) by 29% and 37% in non-smokers and by 35% and 48% in smokers (Dillon et al. 2002). There are several other published data demonstrating antioxidant activity of garlic and garlic preparations, however, as mentioned below, garlic can exert some adverse effects, which could be related to oxidative stress. There is an increasing amount of evidence that depending on the experimental model, the concentration of the compounds and other possible factors, garlic preparations act either as antioxidants or pro-oxidants. Filomeni et al. (2003) demonstrated that DADS increased ROS formation in cancer cells. In addition, DATS-induced prostate cancer cell death has been related to increased ROS formation (Xiao et al. 2004). Protective effects of over-expressed catalase or low molecular weight antioxidants against DATS-induced cell death support the role of ROS in cancer cell death. The dual role of antioxidant compounds exhibiting pro-oxidant activity is quite puzzling. In the case of the pro-oxidant activity of garlic our knowledge still is not complete. Interestingly, it was observed that in genetically modified prostate cancer cells, in a way that they could not activate c-jun kinases (JNK), DATS acted as an antioxidant. These data suggested that DATS-induced ROS formation is JNK-dependent. In fact, it was observed that JNK activation led to ferritin degradation (Antosiewicz et al. 2006). Ferritin is a multi-subunit protein, whose main function is sequestering iron. Ferritin degradation leads to liberation of iron which in reactions with hydrogen peroxide, lipid hydroperoxides and other compounds can generate several radical species including hydroxyl radical. DATS-induced ferritin degradation was accompanied by an increase in labile iron pool (LIP). An iron chelator completely abolished DATS-induced ROS formation which suggested that it is an iron-dependent process (Antosiewicz et al. 2006). The exact mechanism of JNK-stimulated ferritin degradation is not known. Interestingly, overproduction of ROS leads to the activation of JNK and there is some evidence that DATS-induced JNK activation is ROS-dependent. These data suggest that DATS, and possible other OSCs, in addition to iron-dependent ROS, stimulate formation of other free radical species. On the other hand it was shown that DADS treatment increased the ferritin H protein levels in the liver (Thomas et al. 2002). Altogether, these data indicate that OSCs might act as pro-oxidants by increasing ferritin degradation and LIP or as antioxidants when ferritin levels are increased.
10.7 Adverse Effects of Garlic and Its Interactions with Drugs
Considering the fact that garlic has been consumed by humans for centuries, it is generally accepted to be a safe food. However, few studies reported on some toxic effects of garlic. Some of these effects are possibly related to its pro-oxidant activity. Gastrointestinal irritation may occur after the consumption of raw garlic, fresh garlic juice, dehydrated raw garlic powder or even after the intake of garlic tablets (Hoshino et al. 2001; Borrelli et al. 2007). Clinical studies have shown that garlic at therapeutic doses may cause mild gastric mucosa damage and around 6% of patients complained of nausea and 0.8% of bloating (Borrelli et al. 2007). Experiments performed on animals also showed several adverse effects of garlic. Rats that were fed with high amounts of raw garlic, DATS or DADS developed anaemia and demonstrated lysis of red blood cells (Munday et al. 2003). Garlic extract on one hand has been shown to reduce the clastogenic effect of some toxins in mice, on the other hand at higher concentrations it induced a clastogenic effect (Das et al. 1996). Studies performed on dogs showed that raw garlic powder caused severe damage, including erosion of gastric mucosa. Dehydrated, boiled garlic powder also caused reddening of the mucosa, whereas AGE did not cause any undesirable effects (Hoshino et al. 2001). In rats raw garlic juice at a dose of 5 ml/kg resulted in the death of some animals due to stomach injury after 21 days (Nakagawa et al. 1980). The surviving rats exhibited swelling of the liver, hypertrophy of the spleen and adrenal glands, and the decrease of erythrocytes and various morphological changes were clearly observed after 3 and 8 days in the group administered with high doses of raw garlic juice. Such changes were not observed at any time with the use of extracted-aged garlic juice (Nakagawa et al. 1980). Similar observations were done on animals treated with aqueous garlic extract (200 g/L drinking water) for 10 days, where liver injury and local inflammatory response was observed (Joseph et al. 1989). AGE has been reported to protect against heat-induced inhibition of spermatogenesis in rats whereas the administration of garlic powder (50 mg/day) led to the inhibition of spermatogenesis in rats and decreased Leydig cell function (Dixit and Joshi 1982; Hammami et al. 2008).
Despite several studies demonstrating adverse effects of garlic it can be concluded that it is a relatively safe food component. In most animal studies a very high dose of garlic was applied, which is not normally consumed. In addition, it can be assumed that consumption of garlic with other food might reduce eventual toxic effect of the former one.
The biological effects of garlic are also related to the xenobiotic metabolism. The process of detoxification of pro-cancerogens consists of two phases. Phase I, catalyzed by the isoforms of P450 cytochromes, relies on reactions of hydroxylation, oxidation, hydrolysis, demethylation and some others yielding modified xenobiotics. Unfortunately, some products of Phase I reactions could be more toxic than parent compounds. Reactions catalyzed by Phase II detoxification enzymes promote the elimination of drugs and carcinogens from the body. Therefore, the activity of Phase II enzymes such as glutation S-transferase (GST), epoxide hydrolase, quinone oxidoreductase (NQO1) and glucuronate transferase may prevent cancerogenesis by increasing the clearance rate of toxic chemicals. The main goal of both phases of xenobiotic metabolism is to increase polarity, solubility and their subsequent excretion.
In the case of Phase II enzymes the data are consistent and clearly show that garlic as well as garlic derived OSCs increase their activity. For example, Chen et al. (2004) reported that the gene expression of NQO1 and heme oxygenase increased upon treatment with DADS or DATS. Many reports showed that OSCs increased GST activity and that allyl derivatives are more potent inducers of GST than propyl-containing OSCs (Hu et al. 1997).
The effect of OSCs on Phase I enzymes is controversial. For example, Davenport and Wargovich demonstrated that in rats, gastric intubation with a single dose of 200 mg/kg DAS, DADS or allyl methyl sulfide (AMS) decreased hepatic P450–2E1 protein by 45, 25, and 47%, respectively. On the other hand, DAS and AMS increased hepatic P450–1A2 protein levels by 282 and 70%, and DAS increased P450–1A1 protein levels by 684% (Davenport and Wargovich 2005). 1,2-dimethylhydrazine is a carcinogen activated by P450–2E1, therefore inhibition of its activity by OSCs seems to be the main mechanism of chemo-prevention (Wargovich 1987). Interestingly, it was observed that mice lacking expression of CYP1A1, CYP1B1, CYP1A2, and CYP2E1 do not differ from wild-type mice. However, the CYP null mice have altered responses to the toxic and carcinogenic effects of chemicals as compared with wild-type mice (Gonzalez and Kimura 2003). Therefore, it can be speculated that increased activity of some P450 isoenzymes induced by OSCs could elevate toxicity of some xenobiotics but on the other hand can be also protective. Induction of Phase I and II enzymes by garlic may increase clearness of some chemo-therapeutics. For example, garlic lowered the serum level of saquinavir, which is an anti-HIV drug, by as much as 50% (Piscitelli et al. 2002).
10.8 Other Therapeutic Applications
The therapeutic use of antitumor drugs has been limited by their toxicity. Treated patients often experience side effects such as nausea, vomiting, diarrhea, stomatitis, gastrointestinal ulceration and mucositis. For example, methotrexate (MTX), is an anticancer drug that has been shown to be highly effective against various kinds of cancers, however, it is highly toxic to the rapidly dividing cells of intestinal crypts. Interestingly, weight loss in rats treated with MTX and severity of jejunal damage was reduced by provision of AGE. Moreover, experiments performed on intestinal epithelial, IEC-6 cells showed that AGE almost completely suppressed MTX-induced cell death (Horie et al. 2001). These data suggest that AGE could be a supplement of choice for patients experiencing adverse effects of chemotherapy.
The mechanism of anticancer activity of garlic is far from being completely understood, however, potentiating the immune system could be a very important one. Decline in immune function is observed in advanced cancer patients and AGE has been shown to prevent the decline of NK cell number and activity in these patients (Ishikawa et al. 2006). Furthermore, AGE stimulated immune functions, such as proliferation of lymphocyte, cytokine release, NK activity and phagocytosis. Moreover, a protein fraction from garlic has been demonstrated to enhance the cytotoxicity of human peripheral blood lymphocytes against M14 melanoma cells (Morioka et al. 1993).
10.9 Summary and Conclusions
Inhibition of cancer development is a remarkable property of garlic and its constituents documented in a large body of research showing that OSCs suppress each stage of the carcinogenesis process (Fig. 10.2). The most convincing data come from pre-clinical studies which demonstrate preventive activity of OSCs in chemically induced cancers in animal models as well as the ability of garlic constituents to inhibit cancer cell division, survival and metastasis both in vitro (cell cultures) and in vivo (xenograft models). However, epidemiological data and intervention trials in humans are still scarce or lacking. Thus, in order to use garlic constituents/preparations for cancer patients, additional efforts are required to: (1) assess clinical potential of OSCs in carefully designed clinical trials; (2) determine plasma and tissue concentration of OSCs in humans to relate it to effective anticancer concentrations used in vitro; (3) evaluate toxic amount of OSCs and their side effects on normal tissue.
References
Antosiewicz, J., Herman-Antosiewicz, A., Marynowski, S. W., et al. (2006). c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Research, 66, 5379–5386.
Aquilano, K., Filomeni, G., Baldelli, S., et al. (2007). Neuronal nitric oxide synthase protects neuroblastoma cells from oxidative stress mediated by garlic derivatives. Journal of Neurochemistry, 101, 1327–1337.
Arunkumar, A., Vijayababu, M. R., Gunadharini, N., et al. (2007). Induction of apoptosis and histone hyperacetylation by diallyl disulfide in prostate cancer cell line PC-3. Cancer Letters, 251, 59–67.
Arunkumar, A., Vijayababu, M. R., Srinivasan, N., et al. (2006a). Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3. Molecular and Cellular Biochemistry, 288, 107–113.
Arunkumar, A., Vijayababu, M. R., Venkataraman P, et al. (2006b). Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic. Biological & Pharmaceutical Bulletin, 29, 375–379.
Balasenthil, S., Ramachandran, C. R., & Nagini, S. (2001). Prevention of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis by garlic. Fitoterapia, 72, 524–531.
Ban, J. O., Yuk, D. Y., Woo, K. S., et al. (2007). Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells. Journal of Pharmacological Sciences, 104, 374–383.
Ban, J. O., Lee, H. S., Jeong, H. S., et al. (2009). Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B. Molecular Cancer Research: MCR, 7, 870–879.
Block, E. (1985). The chemistry of garlic and onions. Scientific American, 252, 114–119.
Borrelli, F., Capasso, R., & Izzo, A. A. (2007). Garlic (Allium sativum L.): Adverse effects and drug interactions in humans. Molecular Nutrition & Food Research, 51, 1386–1397.
Busch, C., Jacob, C., Anwar, A., et al. (2010). Diallylpolysulfides induce growth arrest and apoptosis. International Journal of Oncology, 36, 743–749.
Cavallito, C. J., & Bailey, J. H. (1944). Alicin, the antibacterial principle of Allium sativum. I. Isolation, physical properties and antibacterial action. Journal of the American Chemical Society, 66, 1950–1951.
Challier, B., Perarnau, J. M., & Viel, J. F. (1998). Garlic, onion and cereal fibre as protective factors for breast cancer: A French case-control study. European Journal of Epidemiology, 14, 737–747.
Chen, C., Pung, D., Leong, V., et al. (2004). Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: Effect of chemical structure and stress signals. Free Radical Biology & Medicine, 37, 1578–1590.
Cheng, J. Y., Meng, C. L., Tzeng, C. C., et al. (1995). Optimal dose of garlic to inhibit dimethylhydrazine-induced colon cancer. World Journal of Surgery, 19, 621–655 (discussion 25–6).
Chu, Q., Lee, D. T., Tsao, S. W., et al. (2007). S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU International, 99, 925–932.
Cohen, L. A., Zhao, Z., Pittman, B., et al. (1999). S-allylcysteine, a garlic constituent, fails to inhibit N-methylnitrosourea-induced rat mammary tumorigenesis. Nutrition and Cancer, 35, 58–63.
Das, A., Banik, N. L., & Ray, S. K. (2007). Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer, 110, 1083–1095.
Das, T., Choudhury, A. R., Sharma, A., et al. (1996). Effects of crude garlic extract on mouse chromosomes in vivo. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 34, 43–47.
Davenport, D. M., & Wargovich, M. J. (2005). Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 43, 1753–1762.
Dillon, S. A., Lowe, G. M., Billington, D., et al. (2002). Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F(2 alpha) in smoking and nonsmoking men and women. The Journal of Nutrition, 132, 168–171.
Dillon, S. A., Burmi, R. S., Lowe, G. M., et al. (2003). Antioxidant properties of aged garlic extract: An in vitro study incorporating human low density lipoprotein. Life Sciences, 72, 1583–1594.
Dirsch, V. M., Gerbes, A. L., & Vollmar, A. M. (1998). Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB. Molecular Pharmacology, 53, 402–407.
Dirsch, V. M., Antlsperger, D. S., Hentze, H., et al. (2002). Ajoene, an experimental anti-leukemic drug: Mechanism of cell death. Leukemia, 16, 74–83.
Dixit, V. P., & Joshi, S. (1982). Effects of chronic administration of garlic (Allium sativum Linn) on testicular function. Indian Journal of Experimental Biology, 20, 534–536.
Dorant, E., van den Brandt, P. A., & Goldbohm, R. A. (1994) A prospective cohort study on Allium vegetable consumption, garlic supplement use, and the risk of lung carcinoma in The Netherlands. Cancer Research, 54, 6148–6153.
Dorant, E., van den Brandt, P. A., & Goldbohm, R. A. (1995). Allium vegetable consumption, garlic supplement intake, and female breast carcinoma incidence. Breast Cancer Research and Treatment, 33, 163–170.
Dorant, E., van den Brandt, P. A., & Goldbohm, R. A. (1996a). A prospective cohort study on the relationship between onion and leek consumption, garlic supplement use and the risk of colorectal carcinoma in The Netherlands. Carcinogenesis, 17, 477–484.
Dorant, E., van den Brandt, P. A., & Goldbohm, R. A., et al. (1996b). Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterol, 110, 12–20.
Druesne, N., Pagniez, A., Mayeur, C., et al. (2004a). Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis, 25, 1227–1236.
Druesne, N., Pagniez, A., Mayeur, C., et al. (2004b). Repetitive treatments of colon HT-29 cells with diallyl disulfide induce a prolonged hyperacetylation of histone H3 K14. Annals of the New York Academy of Sciences, 1030, 612–621.
Dwivedi, C., Rohlfs, S., Jarvis, D., et al. (1992). Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide. Pharmaceutical Research, 9, 1668–1670.
Filomeni, G., Aquilano, K., Rotilio, G., et al. (2003). Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Research, 63, 5940–5949.
Galeone, C., Pelucchi, C., Levi, F., et al. (2006). Onion and garlic use and human cancer. The American Journal of Clinical Nutrition, 84, 1027–1032.
Gao, C. M., Takezaki, T., Ding, J. H., et al. (1999). Protective effect of allium vegetables against both esophageal and stomach cancer: A simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China. Japanese Journal of Cancer Research: Gann, 90, 614–621.
Gapter, L. A., Yuin, O. Z., & Ng, K. Y. (2008). S-Allylcysteine reduces breast tumor cell adhesion and invasion. Biochemical and Biophysical Research Communications, 367, 446–451.
Giovannucci, E., Rimm, E. B., Stampfer, M. J., et al. (1994). Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Research, 54, 2390–2397.
Gonzalez, F. J., & Kimura, S. (2003). Study of P450 function using gene knockout and transgenic mice. Archives of Biochemistry and Biophysics, 409, 153–158.
Ha, M. W., Ma, R., Shun, L. P., et al. (2005). Effects of allitridi on cell cycle arrest of human gastric cancer cells. World Journal of Gastroenterology: WJG, 11, 5433–5437.
Hammami, I., Nahdi, A., Mauduit, C., et al. (2008). The inhibitory effects on adult male reproductive functions of crude garlic (Allium sativum) feeding. Asian Journal of Andrology, 10, 593–601.
Hansson, L. E., Nyren, O., Bergstrom, R., et al. (1993). Diet and risk of gastric cancer. A population-based case-control study in Sweden. International Journal of Cancer. Journal International du Cancer, 55, 181–189.
Hayes, M. A, Rushmore, T. H., & Goldberg, M. T. (1987). Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis, 8, 1155–1157.
Herman-Antosiewicz, A., & Singh, S. V. (2005). Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. The Journal of Biological Chemistry, 280, 28519–28528.
Herman-Antosiewicz, A., Stan, S. D., Hahm. E. R., et al. (2007). Activation of a novel ataxia-telangiectasia mutated and Rad3 related/checkpoint kinase 1-dependent prometaphase checkpoint in cancer cells by diallyl trisulfide, a promising cancer chemopreventive constituent of processed garlic. Molecular Cancer Therapeutics, 6, 1249–1261.
Herman-Antosiewicz, A., Kim, Y. A., Kim, S. H., et al. (2010). Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1. Pharmaceutical Research, 27, 1072–1079.
Hong, Y. S., Ham, Y. A., Choi, J. H., et al. (2000). Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Experimental & Molecular Medicine, 32, 127–134.
Horie, T., Awazu, S., Itakura, Y., et al. (2001). Alleviation by garlic of antitumor drug-induced damage to the intestine. The Journal of Nutrition, 131, 1071S–1074S.
Hoshino, T., Kashimoto, N., & Kasuga, S. (2001). Effects of garlic preparations on the gastrointestinal mucosa. The Journal of Nutrition, 131, 1109S–11013S.
Hosono, T., Fukao, T., Ogihara, J., et al. (2005). Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. The Journal of Biological Chemistry, 280, 41487–41493.
Hosono, T., Hosono-Fukao, T., Inada, K., et al. (2008). Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells. Carcinogenesis, 29, 1400–1406.
Howard, E. W., Ling ,M. T., Chua, C. W., et al. (2007). Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 13, 1847–1856.
Howard, E. W., Lee, D. T., Chiu, Y. T., et al. (2008). Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer. International Journal of Cancer. Journal International du Cancer, 122, 1941–1948.
Hsing, A. W., Chokkalingam, A. P., Gao, Y. T., et al. (2002). Allium vegetables and risk of prostate cancer: A population-based study. Journal of the National Cancer Institute, 94, 1648–1651.
Hu, J., Nyren, O., Wolk, A., et al. (1994). Risk factors for oesophageal cancer in northeast China. International Journal of Cancer. Journal International du Cancer, 57, 38–46.
Hu, X., Benson, P. J., Srivastava, S. K., et al. (1997). Induction of glutathione S-transferase pi as a bioassay for the evaluation of potency of inhibitors of benzo(a)pyrene-induced cancer in a murine model. International Journal of Cancer. Journal International du Cancer, 73, 897–902.
Imai, J., Ide, N., Nagae, S., et al. (1994). Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Medica, 60, 417–420.
Ip, C., Lisk, D. J., & Stoewsand, G. S. (1992). Mammary cancer prevention by regular garlic and selenium-enriched garlic. Nutrition and Cancer, 17, 279–286.
Ishikawa, H,. Saeki, T., Otani, T., et al. (2006). Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. The Journal of Nutrition, 136, 816S–820S.
Joseph, P. K., Rao, K. R., & Sundaresh, C. S. (1989). Toxic effects of garlic extract and garlic oil in rats. Indian Journal of Experimental Biology, 27, 977–979.
Karmakar, S., Banik, N. L., Patel, S. J., et al. (2007). Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis, 12, 671–684.
Key, T. J., Silcocks, P. B., Davey, G. K., et al. (1997). A case-control study of diet and prostate cancer. British Journal of Cancer, 76, 678–687.
Kim, J. Y., & Kwon, O. (2009). Garlic intake and cancer risk: An analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims. The American Journal of Clinical Nutrition, 89, 257–264.
Kim, H. J., Chang, W. K., Kim, M. K., et al. (2002) Dietary factors and gastric cancer in Korea: A case-control study. International Journal of Cancer. Journal International du Cancer, 97, 531–535.
Kirsh, V. A., Peters, U., Mayne, S. T., et al. (2007). Prospective study of fruit and vegetable intake and risk of prostate cancer. Journal of the National Cancer Institute, 99, 1200–1209.
Knowles, L. M., & Milner, J. A. (1998). Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutrition and Cancer, 30, 169–174.
Knowles, L. M., & Milner, J. A. (2000). Diallyl disulfide inhibits p34(cdc2) kinase activity through changes in complex formation and phosphorylation. Carcinogenesis, 21, 1129–1134.
Kwon, K. B., Yoo, S. J., Ryu, D. G., et al. (2002). Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochemical Pharmacology, 63, 41–47.
Lan, H., & Lu, Y. Y. (2004). Allitridi induces apoptosis by affecting Bcl-2 expression and caspase-3 activity in human gastric cancer cells. Acta Pharmacologica Sinica, 25, 219–225.
Lawson, L. D., & Wang, Z. J. (2005). Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: Use in measuring allicin bioavailability. Journal of Agricultural and Food Chemistry, 53, 1974–1983.
Lawson, L. D., Wang, Z. J., & Hughes, B. G. (1991). Identification and HPLC quantitation of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Medica, 57, 363–370.
Le Marchand, L., Hankin, J. H., Wilkens, L. R., et al. (1997). Dietary fiber and colorectal cancer risk. Epidemiology (Cambridge, Mass.), 8, 658–665.
Lea, M. A, Randolph, V. M., & Patel, M. (1999). Increased acetylation of histones induced by diallyl disulfide and structurally related molecules. International Journal of Oncology, 15, 347–352.
Lea, M. A., Rasheed, M., Randolph, V. M., et al. (2002). Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine. Nutrition and Cancer, 43, 90–102.
Ledezma, E., Apitz-Castro, R., Cardier, J. (2004). Apoptotic and anti-adhesion effect of ajoene, a garlic derived compound, on the murine melanoma B16F10 cells: Possible role of caspase-3 and the alpha(4)beta(1) integrin. Cancer Letters, 206, 35–41.
Lee, Y. (2008). Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line. International Journal of Molecular Medicine, 21, 765–770.
Levi, F., Pasche, C., La Vecchia, C., et al. (1999). Food groups and colorectal cancer risk. British Journal of Cancer, 79, 1283–1287.
Li, H., Li, H. Q., Wang, Y., et al. (2004). An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chinese Medical Journal, 117, 1155–1160.
Li, M., Ciu, J. R., Ye, Y., et al. (2002a). Antitumor activity of Z-ajoene, a natural compound purified from garlic: Antimitotic and microtubule-interaction properties. Carcinogenesis, 23, 573–579.
Li, M., Min, J. M., Cui, J. R., et al. (2002b). Z-ajoene induces apoptosis of HL-60 cells: Involvement of Bcl-2 cleavage. Nutrition and Cancer, 42, 241–247.
Lin, Y. T., Yang, J. S., Lin, S. Y., et al. (2008). Diallyl disulfide (DADS) induces apoptosis in human cervical cancer Ca Ski cells via reactive oxygen species and Ca2+-dependent mitochondria-dependent pathway. Anticancer Research, 28, 2791–2799.
Liu, J., Lin, R. I., & Milner, J. A. (1992). Inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and DNA adducts by garlic powder. Carcinogenesis, 13, 1847–1851.
Lu, H. F., Sue, C. C., Yu, C. S., et al. (2004). Diallyl disulfide (DADS) induced apoptosis undergo caspase-3 activity in human bladder cancer T24 cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 42, 1543–1552.
Lund, T., Stokke, T., Olsen, O. E., et al. (2005). Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis. British Journal of Cancer, 92, 1773–1781.
Malki, A., El-Saadani, M., & Sultan, A. S. (2009). Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biology & Therapy, 8, 2175–2185.
Matsuura, N., Miyamae, Y., Yamane, K., et al. (2006). Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. The Journal of Nutrition, 136, 842S–846S.
Morioka, N., Sze, L. L., Morton, D. L., et al. (1993). A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A. Cancer Immunology, Immunotherapy: CII, 37, 316–322.
Munday, R., Munday, J. S., & Munday, C. M. (2003). Comparative effects of mono-, di-, tri-, and tetrasulfides derived from plants of the Allium family: Redox cycling in vitro and hemolytic activity and Phase 2 enzyme induction in vivo. Free Radical Biology & Medicine, 34, 1200–1211.
Nakagawa, H., Tsuta, K., Kiuchi, K., et al. (2001). Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis, 22, 891–897.
Nakagawa, S., Masamoto, K., Sumiyoshi, H., et al. (1980). Effect of raw and extracted-aged garlic juice on growth of young rats and their organs after peroral administration (author’s transl). The Journal of Toxicological Sciences, 5, 91–112.
Nishino, H., Iwashima, A., Itakura, Y., et al. (1989). Antitumor-promoting activity of garlic extracts. Oncology, 46, 277–280.
Park, E. K., Kwon, K. B., Park, K. I., et al. (2002). Role of Ca(2+) in diallyl disulfide-induced apoptotic cell death of HCT-15 cells. Experimental & Molecular Medicine, 34, 250–257.
Peng, C. Y., Graves, P. R., Thoma, R. S., et al. (1997). Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501–1505.
Piscitelli, S. C., Burstein, A. H., Welden, N., et al. (2002). The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2002, 34, 234–238.
Reddy, B. S., Rao, C. V., Rivenson, A., et al. (1993). Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Research, 53, 3493–3498.
Rivlin, R. S. (2001). Historical perspective on the use of garlic. The Journal of Nutrition, 131, 951S–954S.
Sadhana, A. S., Rao, A. R., Kucheria, K., et al. (1988). Inhibitory action of garlic oil on the initiation of benzo[a]pyrene-induced skin carcinogenesis in mice. Cancer Letters, 40, 193–197.
Sakamoto, K., Lawson, L. D., Milner, J. A. (1997). Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells. Nutrition and Cancer, 29, 152–156.
Sanchez, Y., Wong, C., Thoma, R. S., et al. (1997). Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science, 277, 1497–1501.
Schaffer, E. M., Liu, J. Z., Green, J., et al. (1996). Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Cancer Letters, 102, 199–204.
Shirin, H., Pinto, J. T., Kawabata, Y., et al. (2001). Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer research, 61, 725–731.
Sigounas, G., Hooker, J. L., Li, W., et al. (1997). S-allylmercaptocysteine, a stable thioallyl compound, induces apoptosis in erythroleukemia cell lines. Nutrition and Cancer, 28, 153–159.
Singh, A., Arora, A., & Shukla, Y. (2004). Modulation of altered hepatic foci induction by diallyl sulphide in Wistar rats. European Journal Of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), 13, 263–269.
Singh, A., & Shukla, Y. (1998). Antitumor activity of diallyl sulfide in two-stage mouse skin model of carcinogenesis. Biomedical and Environmental Sciences: BES, 11, 258–263.
Singh, S. V., Mohan, R. R., Agarwal, R., et al. (1996). Novel anti-carcinogenic activity of an organosulfide from garlic: Inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. Biochemical and Biophysical Research Communications, 225, 660–665.
Song, J. D., Lee, S. K., Kim, K. M., et al. (2009). Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells. Journal of Biochemical and Molecular Toxicology, 23, 71–79.
Sparnins, V. L., Mott, A. W., Barany, G., et al. (1986). Effects of allyl methyl trisulfide on glutathione S-transferase activity and BP-induced neoplasia in the mouse. Nutrition and Cancer, 8, 211–215.
Sparnins, V. L., Barany, G., & Wattenberg, L. W. (1988). Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis, 9, 131–134.
Steinmetz, K. A., Kushi, L. H., Bostick, R. M., et al. (1994). Vegetables, fruit, and colon cancer in the Iowa Women’s Health Study. American Journal of Epidemiology, 139, 1–15.
Sumioka, I., Matsura, T., Kasuga, S., et al. (1998). Mechanisms of protection by S-allylmercaptocysteine against acetaminophen-induced liver injury in mice. Japanese Journal of Pharmacology, 78, 199–207.
Sumiyoshi, H., & Wargovich, M. J. (1990). Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Research, 50, 5084–5087.
Sundaram, S. G., & Milner, J. A. (1996a). Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis, 17, 669–673.
Sundaram, S. G., & Milner, J. A. (1996b). Diallyl disulfide inhibits the proliferation of human tumor cells in culture. Biochimica et Biophysica Acta, 1315, 15–20.
Sundaram, S. G., & Milner, J. A. (1996c). Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. The Journal of Nutrition, 126, 1355–1361.
Suzui, N., Sugie, S., Rahman, K. M., et al. (1997). Inhibitory effects of diallyl disulfide or aspirin on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats. Japanese Journal of Pharmacology, 88, 705–711.
Takahashi, S., Hakoi, K., Yada, H., et al. (1992). Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis, 13, 1513–1518.
Takezaki, T., Gao, C. M., Ding, J. H., et al. (1999). Comparative study of lifestyles of residents in high and low risk areas for gastric cancer in Jiangsu Province, China; with special reference to allium vegetables. Journal of Epidemiology/Japan Epidemiological Association, 9, 297–305.
Tan, L. M., Zhang, M. X., Luo, H. M., et al. (2004). The initiation of G2/M checkpoint by diallyl disulfide requires the activation of p38 MAP kinase in HL-60 cells. Zhonghua Xue Ye Xue Za Zhi, 25, 273–276.
Tanaka, S., Haruma, K., Kunihiro, M., et al. (2004). Effects of aged garlic extract (AGE) on colorectal adenomas: A double-blinded study. Hiroshima Journal of Medical Sciences, 53, 39–45.
Taylor, P., Noriega, R., Farah, C., et al. (2006). Ajoene inhibits both primary tumor growth and metastasis of B16/BL6 melanoma cells in C57BL/6 mice. Cancer Letters, 239, 298–304.
Thejass, P., & Kuttan, G. (2007a). Antiangiogenic activity of Diallyl Sulfide (DAS). International Immunopharmacology, 7, 295–305.
Thejass, P., & Kuttan, G. (2007b). Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by diallyl disulfide (DADS). Life Sciences, 80, 515–521.
Thomas, M., Zhang, P., Noordine, M. L., et al. (2002). Diallyl disulfide increases rat h-ferritin, L-ferritin and transferrin receptor genes in vitro in hepatic cells and in vivo in liver. The Journal of Nutrition, 132, 3638–3641.
Tilli, C. M., Stavast-Kooy, A. J., Vuerstaek, J. D., et al. (2003). The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis. Archives of Dermatological Research, 295, 117–123.
Uda, N., Kashimoto, N., Sumioka, I., et al. (2006). Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis. The Journal of Nutrition, 136, 855S-860S.
Wang, H. C., Yang, J. H., Hsieh, S. C., et al. (2010a). Allyl sulfides inhibit cell growth of skin cancer cells through induction of DNA damage mediated G2/M arrest and apoptosis. Journal of Agricultural and Food Chemistry, 58, 7096–7103.
Wang, Y. B., Qin, J., Zheng, X. Y., et al. (2010b). Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 17, 363–368.
Wargovich, M. J. (1987). Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis, 8, 487–489.
Wargovich, M. J., Woods, C., Eng, V. W., et al. (1988). Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Research, 48, 6872–6875.
Wattenberg, L. W., Sparnins, V. L., & Barany, G. (1989). Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Research, 49, 2689–2692.
Weinberg, D. S., Manier, M. L., Richardson, M. D., et al. (1993). Identification and quantification of organosulfur compliance markers in a garlic extract. Journal of Agriculture and Food Chemistry, 41, 37–41.
Witte, J. S., Longnecker, M. P., Bird, C. L., et al. (1996). Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps. American Journal of Epidemiology, 144, 1015–1025.
Wu, C. C., Chung, J. G., Tsai, S. J., et al. (2004). Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 42, 1937–1947.
Wu, X. J., Kassie, F., & Mersch-Sundermann, V. (2005). The role of reactive oxygen species (ROS) production on diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carcinoma cells. Mutation Research, 579, 115–124.
Xiao, D., & Singh, S. V. (2006). Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis, 27, 533–540.
Xiao, D., Pinto, J. T., Soh, J. W., et al. (2003). Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Research, 63, 6825–6837.
Xiao, D., Choi, S., Johnson, D. E., et al. (2004). Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene, 23, 5594–5606.
Xiao, D., Herman-Antosiewicz, A., Antosiewicz, J., et al. (2005a). Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc 25 C. Oncogene, 24, 6256–6268.
Xiao, D., Pinto, J. T., Gundersen, G. G., et al. (2005b). Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Molecular Cancer Therapeutics, 4, 1388–1398.
Xiao, D., Lew, K. L., Kim, Y. A., et al. (2006a). Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 12, 6836–6843.
Xiao, D., Li, M., Herman-Antosiewicz, A., et al. (2006b). Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2. Nutrition and Cancer, 55, 94–107.
Xiao, D., Zeng, Y., Hahm, E. R., et al. (2009). Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells. Environmental and Molecular Mutagenesis, 50, 201–212.
Yang, C. S., Chhabra, S. K., Hong, J. Y., et al. (2001). Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. The Journal of Nutrition, 131, 1041S–1045S.
Yang, J. S., Chen, G. W., Hsia, T. C., et al. (2009). Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases casade and mitochondrial-dependent pathways. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 47, 171–179.
You, W., Chang, Y., Zhang, L., et al. (1999). An epidemiologic and preventive study on a high-risk area for gastric cancer in Linqu County, Shandong Province. Chinese Journal of Preventive Veterinary Medicine, 33, 52–54.
You, W. C., Blot, W. J., Chang, Y. S., et al. (1989). Allium vegetables and reduced risk of stomach cancer. Journal of the National Cancer Institute, 81, 162–164.
You, W. C., Zhang, L., Gail, M. H., et al. (1998). Precancerous lesions in two counties of China with contrasting gastric cancer risk. International Journal of Epidemiology, 27, 945–948.
You, W. C., Brown, L. M., Zhang, L., et al. (2006). Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. Journal of the National Cancer Institute, 98, 974–983.
Yuan, J. P., Wang, G. H., Ling, H., et al. (2004). Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways. World Journal of Gastroenterology: WJG, 10, 2731–2734.
Zhang, Z. M., Yang, X. Y., Deng, S. H., et al. (2007). Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Chinese Medical Journal, 120, 1336–1342.
Zheng, W., Blot, W. J., Shu, X. O., et al. (1992a). Diet and other risk factors for laryngeal cancer in Shanghai, China. American Journal of Epidemiology, 136, 178–191.
Zheng, W., Blot, W. J., Shu, X. O., et al. (1992b). A population-based case-control study of cancers of the nasal cavity and paranasal sinuses in Shanghai. International Journal of Cancer. Journal International du Cancer, 52, 557–561.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Herman-Antosiewicz, A., Kawiak, A., Antosiewicz, J. (2011). An Evidence-based Perspective of Allium Sativum (Garlic) for Cancer Patients. In: Cho, W. (eds) Evidence-based Anticancer Materia Medica. Evidence-based Anticancer Complementary and Alternative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0526-5_10
Download citation
DOI: https://doi.org/10.1007/978-94-007-0526-5_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0525-8
Online ISBN: 978-94-007-0526-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)